Avenue Therapeutics ATXI

Jump To Section

    $

    9
    8
    7
    6
    5
    4
    3
    2
    1
    0
    0
    9
    8
    7
    6
    5
    4
    3
    2
    1
    0
    0
    .
    9
    8
    7
    6
    5
    4
    3
    2
    1
    0
    0
    -$0.01 (-1.00%)Past DayToday's Volume:
    9
    8
    7
    6
    5
    4
    3
    2
    1
    0
    0
    9
    8
    7
    6
    5
    4
    3
    2
    1
    0
    0
    9
    8
    7
    6
    5
    4
    3
    2
    1
    0
    0
    ,
    9
    8
    7
    6
    5
    4
    3
    2
    1
    0
    0
    9
    8
    7
    6
    5
    4
    3
    2
    1
    0
    0

    Relative Strength Index (RSI)

    - The Relative Strength Index (RSI) is a momentum oscillator that measures the speed and change of price movements. It is typically used to identify overbought or oversold conditions in financial markets.

    - The RSI is calculated using the following formula:

    RSI = 100 - (100 / (1 + RS))

    Where RS is the ratio of the average gains to the average losses over a specified period.

    - The default time period used is 14 days.

    - RSI values range between 0 and 100.

    RSI values above 70 are considered overbought (indicating a potentially opportune time to sell)

    RSI values below 30 are considered oversold (indicating a potentially opportune time to buy)

    RSI is not a perfect indicator and should be used in conjunction with other technical analysis tools, this is for informational purposes only and is not a substitute for professional financial advice.

    About

    Business overview of Avenue Therapeutics (ATXI)
    Avenue Therapeutics Inc is a specialty pharmaceutical company focused on the development and commercialization of therapies for the treatment of rare and neurologic diseases. It focuses on developing its product candidate, AJ201, for spinal and bulbar muscular atrophy, BAER-101, for the treatment of epilepsy and panic disorders, and IV Tramadol for the management of moderate-to-moderately-severe pain in adults.

    Key Insights

    Critical company metrics and information

    • Latest Closing Price

      $0.98

    • Market Cap

      $2.01 Million

    • Price-Earnings Ratio

      -0.51

    • Total Outstanding Shares

      2.05 Million Shares

    • Total Employees

      3

    • Dividend

      No dividend

    • IPO Date

      June 27, 2017

    • SIC Description

      Pharmaceutical Preparations

    • Primary Exchange

      NASDAQ

    • Type

      Common Stock

    • Headquarters

      1111 kane concourse, Bay harbor islands, FL, 33154

    • Homepage

      https://www.avenuetx.com

    Historical Stock Splits

    If you bought 1,125 shares of ATXI before September 23, 2022, you'd have 1 share today.
    Execution DateSplit Amount
    April 26, 20241-for-75 (Reverse Split)
    September 23, 20221-for-15 (Reverse Split)

    Cash Flow Statement

    July 1, 2024 to September 30, 2024
    MetricValue
    Net Cash Flow$0
    Net Cash Flow From Operating Activities, Continuing$-2.89 Million
    Net Cash Flow From Investing Activities$2.32 Million
    Net Cash Flow From Financing Activities, Continuing$567,000
    Net Cash Flow From Investing Activities, Continuing$2.32 Million
    Net Cash Flow, Continuing$0

    Income Statement

    July 1, 2024 to September 30, 2024
    MetricValue
    Income/Loss From Continuing Operations After Tax$-3.09 Million
    Preferred Stock Dividends And Other Adjustments$0
    Net Income/Loss Available To Common Stockholders, Basic$-3.08 Million
    Income/Loss From Continuing Operations Before Tax$-3.09 Million
    Net Income/Loss Attributable To Noncontrolling Interest$-11,000
    Basic Earnings Per Share$-1.92

    Comprehensive Income

    July 1, 2024 to September 30, 2024
    MetricValue
    Comprehensive Income/Loss$-3.09 Million
    Comprehensive Income/Loss Attributable To Parent$-3.09 Million
    Comprehensive Income/Loss Attributable To Noncontrolling Interest$0
    Other Comprehensive Income/Loss$0

    Balance Sheet

    July 1, 2024 to September 30, 2024
    MetricValue
    Liabilities And Equity$2.63 Million
    Liabilities$973,000
    Current Assets$2.63 Million
    Assets$2.63 Million
    Current Liabilities$973,000
    Equity Attributable To Parent$2.61 Million

    Historical Dividends

    Announcement DatePayment DateRecord DateAmountFrequency
    No historical dividends

    Recent Headlines From The Web

    Latest news, press releases, and media coverage about ATXI from trusted financial sources
      Boost your savings and earn 4.15% APY with a Marcus by Goldman Sachs savings account, a rate that's 8x the national averagewhen signing up with Financhle. No fees, no minimum deposits, backed by the financial expertise of Goldman Sachs. Terms apply.
      All TickersEarnings CalendarNews ArticlesAbout UsPrivacy & Cookies Info

      â“’ 2025 Financhle. All Rights Reserved.